
Sign up to save your podcasts
Or


In this special edition episode of Tales from the Heart, host Lisa Salsberg and Dr. Milind Desai of Clevaland discuss the arrival of the new drug Camzyos. Camzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source of obstructive HCM
By Hypertrophic Cardiomyopathy Association / Lisa Salberg5
88 ratings
In this special edition episode of Tales from the Heart, host Lisa Salsberg and Dr. Milind Desai of Clevaland discuss the arrival of the new drug Camzyos. Camzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source of obstructive HCM

78,704 Listeners

37,578 Listeners

12,074 Listeners

113,434 Listeners

56,991 Listeners

16,512 Listeners

47,568 Listeners